Study seeks to predict which teens benefit from brain stimulation and therapy
NCT ID NCT07283419
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 163 teens with major depression to see if family factors (like conflict or closeness) and cognitive skills (like attention and planning) could predict how well they respond to a combination of repetitive transcranial magnetic stimulation (rTMS) and group cognitive behavioral therapy. The goal was to identify early clues that might help personalize treatment. The study is complete and focused on gathering knowledge, not testing a new cure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
repetitive transcranial magnetic stimulation (rTMS) and group cognitive behavioral therapy
What this could lead to
If successful, this could help doctors personalize depression treatment for teens by identifying who will benefit most from combining rTMS with group therapy.
What could go wrong
This is a completed observational study, not a treatment trial, so it won't prove the therapy works—only which factors might predict response. Results may not apply to all teens with depression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China